2,595
Views
12
CrossRef citations to date
0
Altmetric
Invited Review Articles

Progress in understanding COVID-19: insights from the omics approach

ORCID Icon, , &
Pages 242-252 | Received 08 Aug 2020, Accepted 11 Nov 2020, Published online: 29 Dec 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Heng Wee Tan, Yan-Ming Xu & Andy T. Y. Lau. (2021) Human bronchial-pulmonary proteomics in coronavirus disease 2019 (COVID-19) pandemic: applications and implications. Expert Review of Proteomics 18:11, pages 925-938.
Read now

Articles from other publishers (11)

Beatrix Paton, Pol Herrero, Joaquim Peraire, Antoni del Pino, Silvia Chafino, Javier Martinez-Picado, Fréderic Gómez-Bertomeu, Anna Rull, Núria Canela & Manuel Suárez. (2023) Fucosylated N-glycans as early biomarkers of COVID-19 severity. Frontiers in Immunology 14.
Crossref
Baoxu Lin, Linlin Cheng, Jin Zhang, Mei Yang, Yixiao Zhang, Jianhua Liu & Xiaosong Qin. (2023) Immunology of SARS-CoV-2 infection and vaccination. Clinica Chimica Acta 545, pages 117390.
Crossref
Xiaoping Cen, Fengao Wang, Xinhe Huang, Dragomirka Jovic, Fred Dubee, Huanming Yang & Yixue Li. (2023) Towards precision medicine: Omics approach for COVID-19. Biosafety and Health 5:2, pages 78-88.
Crossref
Chiara Bruzzone, Ricardo Conde, Nieves Embade, José M. Mato & Oscar Millet. (2023) Metabolomics as a powerful tool for diagnostic, pronostic and drug intervention analysis in COVID-19. Frontiers in Molecular Biosciences 10.
Crossref
Ina Maltais-Payette, Fannie Lajeunesse-Trempe, Philippe Pibarot, Laurent Biertho & André Tchernof. (2023) Association between Circulating Amino Acids and COVID-19 Severity. Metabolites 13:2, pages 201.
Crossref
Tsz-Fung Wong, Pui-Kin So & Zhong-Ping Yao. (2022) Advances in rapid detection of SARS-CoV-2 by mass spectrometry. TrAC Trends in Analytical Chemistry 157, pages 116759.
Crossref
Amela Jusic, Konstantinos Stellos, Lino Ferreira, Andrew H. Baker & Yvan Devaux. (2022) (Epi)transcriptomics in cardiovascular and neurological complications of COVID-19. Journal of Molecular and Cellular Cardiology Plus 1, pages 100013.
Crossref
Rafael Luís Luporini, Henrique Pott-Junior, Maria Carolina B. Di Medeiros Leal, Alex Castro, Antonio Gilberto Ferreira, Marcia Regina Cominetti & Fernanda de Freitas Anibal. (2021) Phenylalanine and COVID-19: Tracking disease severity markers. International Immunopharmacology 101, pages 108313.
Crossref
Yolande Ketchanji Mougang, Lorena Di Zazzo, Marilena Minieri, Rosamaria Capuano, Alexandro Catini, Jacopo Maria Legramante, Roberto Paolesse, Sergio Bernardini & Corrado Di Natale. (2021) Sensor array and gas chromatographic detection of the blood serum volatolomic signature of COVID-19. iScience 24:8, pages 102851.
Crossref
Benhong Xu, Yuxuan Lei, Xiaohu Ren, Feng Yin, Weihua Wu, Ying Sun, Xiaohui Wang, Qian Sun, Xifei Yang, Xin Wang, Renli Zhang, Zigang Li, Shisong Fang & Jianjun Liu. (2021) SOD1 is a Possible Predictor of COVID-19 Progression as Revealed by Plasma Proteomics. ACS Omega 6:26, pages 16826-16836.
Crossref
Rachana Singh, Pradhyumna Kumar Singh, Rajnish Kumar, Md. Tanvir Kabir, Mohammad Amjad Kamal, Abdur Rauf, Ghadeer M. Albadrani, Amany A. Sayed, Shaker A. Mousa, Mohamed M. Abdel-Daim & Md. Sahab Uddin. (2021) Multi-Omics Approach in the Identification of Potential Therapeutic Biomolecule for COVID-19. Frontiers in Pharmacology 12.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.